Modern Advancements in Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction

Overview

Journal Ther Adv Urol

Publisher Sage Publications

Date 2021 Aug 5

PMID 34349840

Citations 2

Authors

John Pascoe

Christina Fontaine

Hashim Hashim

Affiliations

Soon will be listed here.

Abstract

A wide variety of minimally invasive surgical techniques are now being offered for treating voiding lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). These options offer an alternative to both medical therapy and traditional surgical options. Minimally invasive surgical treatments in LUTS/BPO boast both day case and local anaesthetic options, with a potentially reduced side effect profile compared to traditional surgical interventions matching the needs for a range of patients. We provide a narrative review of minimally invasive surgical treatments available for BPO in terms of the technology, efficacy, safety, institutional recommendations, cost and potential future developments.

Citing Articles

A Comparative Study on the Clinical Outcomes of Bipolar Radiofrequency Thermotherapy Versus Transurethral Resection of the Prostate in Storage Symptoms Associated With Benign Prostatic Obstruction.

Yuce A, Benli E, Basar D, Yazici I, Cirakoglu A, Nalbant I Int Neurourol J. 2025; 28(4):285-293.

PMID: 39765341 PMC: 11710952. DOI: 10.5213/inj.2346184.092.

Awareness and compliance of urologists in the Middle East with minimally invasive surgical devices for the management of benign prostate hyperplasia.

Azhar R, Elkoushy M, Subahi M, Faisal M, Bakhsh A, Sejiny M Urol Ann. 2024; 16(2):175-183.

PMID: 38818433 PMC: 11135354. DOI: 10.4103/ua.ua_106_23.

Comprehensive Review on Current Controversies and Debate in Prostate Artery Embolization.

Maclean D, Francis Bryant C, Vigneswaran G, Bryant T, Harris M, Somani B Turk J Urol. 2022; 48(3):166-173.

PMID: 35634934 PMC: 9730263. DOI: 10.5152/tud.2022.21337.

References

Worthington J, Taylor H, Abrams P, Brookes S, Cotterill N, Noble S . A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) - the.... Trials. 2017; 18(1):179. PMC: 5392965. DOI: 10.1186/s13063-017-1916-5. View

Roehrborn C, Barkin J, Gange S, Shore N, Giddens J, Bolton D . Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017; 24(3):8802-8813. View

Taktak S, Jones P, Haq A, Rai B, Somani B . Aquablation: a novel and minimally invasive surgery for benign prostate enlargement. Ther Adv Urol. 2018; 10(6):183-188. PMC: 5993070. DOI: 10.1177/1756287218760518. View

Hashim H, Abrams P . Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard?. Eur Urol. 2014; 67(6):1097-1098. DOI: 10.1016/j.eururo.2014.12.022. View

Malaeb B, Yu X, McBean A, Elliott S . National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008). Urology. 2012; 79(5):1111-6. PMC: 3415208. DOI: 10.1016/j.urology.2011.11.084. View

Gao Y, Huang Y, Zhang R, Yang Y, Zhang Q, Hou M . Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial. Radiology. 2014; 270(3):920-8. DOI: 10.1148/radiol.13122803. View

Parsons J, Dahm P, Kohler T, Lerner L, Wilt T . Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020. J Urol. 2020; 204(4):799-804. DOI: 10.1097/JU.0000000000001298. View

Kuntz R, Lehrich K, Ahyai S . Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2007; 53(1):160-6. DOI: 10.1016/j.eururo.2007.08.036. View

Carnevale F, Iscaife A, Yoshinaga E, Moreira A, Antunes A, Srougi M . Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2015; 39(1):44-52. DOI: 10.1007/s00270-015-1202-4. View

10.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T . WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018; 199(5):1252-1261. DOI: 10.1016/j.juro.2017.12.065. View

11.

Knight L, Dale M, Cleves A, Pelekanou C, Morris R . UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update. Appl Health Econ Health Policy. 2022; 20(5):669-680. PMC: 9385790. DOI: 10.1007/s40258-022-00735-y. View

12.

Rukstalis D, Grier D, Stroup S, Tutrone R, DeSouza E, Freedman S . Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2018; 22(3):411-419. PMC: 6760566. DOI: 10.1038/s41391-018-0118-x. View

13.

Gondran-Tellier B, McManus R, Sichez P, Akiki A, Gaillet S, Toledano H . Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter. J Endourol. 2020; 35(1):102-108. DOI: 10.1089/end.2020.0704. View

14.

Hashim H, Worthington J, Abrams P, Young G, Taylor H, Noble S . Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet. 2020; 396(10243):50-61. PMC: 7339133. DOI: 10.1016/S0140-6736(20)30537-7. View

15.

Porpiglia F, Fiori C, Amparore D, Kadner G, Manit A, Valerio M . Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int. 2018; 123(6):1061-1069. DOI: 10.1111/bju.14608. View

16.

Mullhaupt G, Hechelhammer L, Engeler D, Gusewell S, Betschart P, Zumstein V . In-hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial. BJU Int. 2018; 123(6):1055-1060. PMC: 6850481. DOI: 10.1111/bju.14660. View

17.

Insausti I, de Ocariz A, Galbete A, Capdevila F, Solchaga S, Giral P . Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia. J Vasc Interv Radiol. 2020; 31(6):882-890. DOI: 10.1016/j.jvir.2019.12.810. View

18.

Ahyai S, Gilling P, Kaplan S, Kuntz R, Madersbacher S, Montorsi F . Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010; 58(3):384-97. DOI: 10.1016/j.eururo.2010.06.005. View

19.

Mamoulakis C, Ubbink D, de la Rosette J . Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009; 56(5):798-809. DOI: 10.1016/j.eururo.2009.06.037. View

20.

Kawakami J, Nickel J . Acute urinary retention and surgery for benign prostatic hyperplasia: the patient's perspective. Can J Urol. 2001; 6(3):819-822. View